Conclusions. HCV infection is endemic among dialysis centres in Moldavia. Apart from previously wellBackground. Although the epidemiology of hepatitis B (HBV ) and C (HCV ) now seems well established known risk factors for hepatitis infection, our study demonstrates the negative impact of socio-economic for Western European countries, in Central and Eastern Europe <50% of all dialysis centres routinely underdevelopment. Simple measures such as enforced general asepsia rules, careful disinfection and equiptest for hepatitis C antibodies since testing is not available or is not applied to all patients. This study ment sterilization, routine testing of patients from economically disadvantaged areas and monthly, serial describes the prevalence, risk factors and clinical significance of HBV and HCV infection for the haemo-determination of hepatic enzymes should be the common practice in dialysis centres in Romania. dialysis population of the North Eastern region of Romania, Moldavia. Methods. The presence of HBV antigens was deter-Key words: epidemiology; haemodialysis; hepatitis B mined with an ELISA kit ( Wellcome, Abbot) and and C prevalence; risk factors HCV antibodies with the ELISA-3 Ortho-HCV, third generation test. The following individual data were collected: gender, age, duration of dialysis, rural/urban domicile, actual and previous HBV status, actual HCV Introduction status, known acute, clinically evident hepatitis episodes in the last 3 years, monthly alanine aminotransfer-The epidemiology of hepatitis B and C now seems well ase (ALAT ) and aspartate aminotransferase (ASAT ) established for countries in Western Europe [1][2][3][4][5][6][7][8][9]; in levels, complete biochemical hepatic assessment at the Central and Eastern Europe, still <50% of dialysis time of the study, transfusions for the past 3 years and centres routinely test for hepatitis C antibodies, and family history. testing is not available or applied to all patients [10]. Results. HBV and HCV prevalences were 17% (stable Moldavia is one of the three historical Romanian over the last 3 years) and 75%, respectively; co-infection regions, with six counties, a surface area of 46 070 km2 was seen in 10% of the subjects. Hospitalization (noso-(similar to Belgium, 20% of Romania) and a population comial infection) for HBV, blood transfusions and of 4 million (17% of Romania). Due to the country's duration on dialysis for HCV, emerged as the main general dialysis conditions [11] and the region's ecorisk factors for hepatitis infection. Socio-economic nomic conditions (mean personal income per month conditions appear to be equally important for HCV~1 00 $US ), only three dialysis centres ('C.
movement in and out the Moldavian region is negli-Results gible, and renal transplantation absent.
A total of 169 patients (100 males/69 females, urban areas/rural areas=92/77) were studied, mean age= 41.3±11.6, range=20-63 years, with a mean dialysis
Subjects and methods
duration of 25.8 months, range=3-75 months. HBV antigens were found in 29/169 patients, i.e. a prevalence of hepatitis B of 17%. Hepatitis B prevalence for the All haemodialysis patients treated for at least 3 months and previous 3 years is depicted in Figure 1 . HCV antibodhaemodialysis staff members from the Moldavian region ('C. I. Parhon' University Hospital, Iasi, Suceava County ies were found in 111/148 patients (75%). The relative Hospital and Bacau County Hospital ) were tested for hepa-distribution of hepatitis B and C is presented in Table 1 .
titis B and C. The 169 patients enrolled in the study were
A comparison between hepatitis B-positive and negatreated with standard 5 h twice weekly or 5 h thrice weekly tive patients is presented in Table 2 . No difference was dialysis sessions, bicarbonate or acetate buffer (40%/60%) seen in CRF aetiology. Also, no difference was seen in and cuprophane or polysulfone filters (61.5%/38.5%) which hepatitis B prevalence among different age groups. were not re-used. In the Iasi and Bacau centres, concentrate From Table 2 , only dialysis during the last shift of the was prepared in-house (Fresenius automatic mixing systems), day (third ) is associated with a greater prevalence of but distribution was individual. Standard heparin (multihepatitis B.
dose ampoules) was used for anticoagulation. In none of the A comparison between hepatitis C-positive and three dialysis centres there was a special area dedicated for negative patients is presented in Table 3 . No difference previously hepatitis-positive patients.
The following individual data were collected: gender, age, was seen in CRF aetiology. Again, no difference was CRF aetiology, duration of dialysis, rural/urban domicile, seen in hepatitis C prevalence among different age actual and previous hepatitis B status, actual hepatitis C groups. From Table 3 , a longer duration of dialysis, status, known acute, clinically evident hepatitis episodes in together with a larger number of blood transfusions, the last 3 years, monthly alanine aminotransferase (ALAT ) but not the position in the daily programme, are and aspartate aminotransferase (ASAT ) levels, complete related to a greater prevalence of hepatitis C. for B and negative for C, and negative for both HBV antigens were detected with an enzyme-linked immunoassay (ELISA) kit ( Wellcome, Abbot) and HCV viruses-are compared in Figure 2 . All other risk antibodies were also determined with an enzyme immuno-factors analysed in Tables 2 and 3 are essentially assay method ( ELISA-3, Ortho HCV ), third generation. We identical between the four groups.
chose the ELISA-3 test because this system uses three antiNo difference was seen in the prevalence of hepatitis gens (c22-3, c200 and NS5) originating from four regions B or C among the three centres included in the study; of the viral genome (core, NS3, NS4 and NS5), and because moreover, in our centre (Iasi University Hospital 'C. of its superior performance compared with second genera-I. Parhon'), there was no difference in prevalence tion tests.
among the four main dialysis wards (each isolated one A CSTAT programme (Oxford Statistics) was used for the from another). All staff members were hepatitis B or statistical analysis. A x2 test with Yates correction, unpaired C negative.
t-test and Wilcoxon test were applied to the data obtained. All differences were considered significant when P<0.05.
Finally, looking for factors not related directly to the dialysis procedure, we analysed hepatitis prevalence socio-economic conditions in our country. Indeed, a high prevalence was also found in Bucharest's 'Carol at the beginning of the replacement therapy. Thirty four new CRF patients who started dialysis in 1996 Davila' Hospital dialysis centre: 80.6% [26 ] . Also, hepatitis C prevalence among volunteer blood donors were tested for markers of hepatitis B and C. Hepatitis B antigens were absent in all patients, but anti-HCV from Moldavia (n=616 [26 ] ) is 9.4% (when tested with ELISA II ) and 4.6% (when tested with RIBA was detected in 15/17 (47%) before starting HD. No relationship to the number of previous blood trans-III ), i.e. at least seven times higher than in France (0.6%). Finally, third generation assays (used in our fusions or to the known duration of CRF was found.
Retrospective analysis identified only 12 episodes study) can detect more positive patients than first and second generation tests [12] used in the majority of which could be classified as acute hepatitis, with asthenia, jaundice and hepatalgias being present in all these the previous studies.
The striking difference in prevalence seen by us cases. Four of the acute episodes were confirmed as having hepatitis B seroconversion, while the others between the two viruses (with similar molecular size and transmission routes in the general and the haemowere C positive. Hepatic function, at the time of the study, was similar between the negative, non-infected dialysis populations [16 ]) has also been described by others [5, 13, 14, 20, 25] . Co-infection with the B and C and the positive, infected subgroups. By analysis of the peak cytolytic level/year and the number of epi-viruses (10%) was rare in our population compared with much higher rates reported for developed and sodes exceeding the upper limits of ALAT and ASAT, a significantly higher proportion of acute hepatic events non-developed countries 41% . were recorded in the infected subgroups (data presented in Table 4 ). All the 12 clinical acute episodes were associated with an acute, important elevation of Risk factors for hepatitis infection hepatic enzymes.
From our study, the only risk factor for hepatitis B was dialysis during the last (third ) shift of the day.
Discussion
Haemodialysis machine sterilization procedures are similar between the three shifts, but complete disinfection of all surfaces is usually undertaken only at the Our study reports on the prevalence and risk factors of hepatitis B and C in the haemodialysis population end of the day, suggesting a role for nosocomial, horizontal transmission. The increasing HBV antigen of a large Romanian province-Moldavia.
Hepatitis B prevalence varies among studies and prevalence found for the first-third shifts might suggest transmission through the dialysis monitor, which has geographical areas. It has been reported to be as low as 5-7.2% [3,5] to >80% when antibodies against been demonstrated to be possible [27] [28] [29] , especially for machines with an ultrafiltration control device [30] . HBV are examined. Active hepatitis B (HBV-antigen positive) was present in 17% of our patients (unchanged In fact, there was no difference between the different dialysis areas (completely separate rooms and even over the last 3 years), similar to the majority of reports in the literature [4,15-19], and almost comparable different floors) or centres, supporting the vertical transmission hypothesis. As shown by our study, the with that reported for the same area in a high-risk population (dystrophic children from nursing homes, type of membrane (polysulfone vs cellulose and lowflux vs larger pores) did not significantly influence virus n=2355): 21.7% [36 ] Hepatitis C prevalence in the largest studies in transmission. Transmission may have occurred in our centres by sharing of multi-dose heparin ampoules (as Western Europe determined with second generation ELISA assays ranges between 7% [9] and 23-24% shown for HCV by Gilli et al. [30] ), usually opened in the morning and used throughout the whole day. [4,5]. However, in countries close to and similar to Romania, or in developing regions, this figure is signi-We changed this procedure after analysing the results of the present study. and reliable.
